Skip to content

Charcot Marie Tooth Disease Demyelinating Iia 1h C5676926

Published: July 22, 2026Updated: August 25, 2026

A hereditary condition where the nerve covering (myelin) gradually breaks down, causing weakness and sensory changes. It usually begins in childhood or teen years. Care includes physical therapy, foot care, and orthopedic support.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Distal muscle weakness

(neurologic)

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Foot drop

(neurologic)

Sensory loss in distal extremities

(neurologic)

Postural tremor

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive physical therapy program

An intensive physical therapy regimen focusing on preserving muscle strength, preventing contractures through targeted stretching, improving balance and proprioception, and maintaining functional mobility through individualized exercise prescription.

physical_therapy
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Custom orthopedic footwear and orthoses

Provision of custom-molded shoes, ankle-foot orthoses, and hand splints as needed to support weak muscles, stabilize joints, prevent deformities, and improve functional mobility and safety during ambulation.

lifestyle

Additional treatment options

Corrective orthopedic surgery

Surgical interventions to address severe skeletal deformities including foot reconstruction, joint stabilization procedures, and tendon transfers when conservative management fails to provide adequate symptom control or functional improvement.

surgical

Multidisciplinary disease monitoring

Regular coordinated follow-up with neurology, physiatry, orthopedics, and physical therapy to systematically track disease progression, evaluate treatment effectiveness, and proactively address emerging complications.

monitoring

Aquatic therapy and alternative exercise

Water-based therapy in warm pools to allow resistance training and aerobic exercise with reduced joint stress. May include alternative approaches such as tai chi for balance improvement and yoga for flexibility.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Charcot Marie Tooth Disease Demyelinating Iia 1h C5676926?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Pareyson D, Saveri P, Pisciotta C. New developments in the diagnosis and treatment of Charcot-Marie-Tooth disease. Nat Rev Neurol. 2023;19(8):493-506.

guideline2023
2

Zimon S, Baets J, Timmerman V, Horn M. Molecular mechanisms of Charcot-Marie-Tooth type 2A: from clinical features to therapy. Neuromolecular Med. 2020;22(4):425-441.

review2020
3

Pisciotta C, Faccani V, Manganelli F, et al. Analysis of outcome measures in Charcot-Marie-Tooth disease clinical trials. Brain. 2022;145(9):3117-3129.

clinical_trial2022
4

Lorch MP, Lehner T, Nicolau M. Charcot-Marie-Tooth disease subtypes and genetic testing considerations. Lancet Neurol. 2021;20(10):784-798.

review2021

Medication Comparisons

Compare medications used to treat Charcot Marie Tooth Disease Demyelinating Iia 1h C5676926. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy